These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
820 related articles for article (PubMed ID: 24145819)
1. Modification of the relationship of the apolipoprotein E ε4 allele to the risk of Alzheimer disease and neurofibrillary tangle density by sleep. Lim AS; Yu L; Kowgier M; Schneider JA; Buchman AS; Bennett DA JAMA Neurol; 2013 Dec; 70(12):1544-51. PubMed ID: 24145819 [TBL] [Abstract][Full Text] [Related]
2. Association of Cortical β-Amyloid Protein in the Absence of Insoluble Deposits With Alzheimer Disease. Yu L; Petyuk VA; Tasaki S; Boyle PA; Gaiteri C; Schneider JA; De Jager PL; Bennett DA JAMA Neurol; 2019 Jul; 76(7):818-826. PubMed ID: 31009033 [TBL] [Abstract][Full Text] [Related]
3. Association of Apolipoprotein E ε4 With Transactive Response DNA-Binding Protein 43. Wennberg AM; Tosakulwong N; Lesnick TG; Murray ME; Whitwell JL; Liesinger AM; Petrucelli L; Boeve BF; Parisi JE; Knopman DS; Petersen RC; Dickson DW; Josephs KA JAMA Neurol; 2018 Nov; 75(11):1347-1354. PubMed ID: 30422173 [TBL] [Abstract][Full Text] [Related]
4. Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype. Berg L; McKeel DW; Miller JP; Storandt M; Rubin EH; Morris JC; Baty J; Coats M; Norton J; Goate AM; Price JL; Gearing M; Mirra SS; Saunders AM Arch Neurol; 1998 Mar; 55(3):326-35. PubMed ID: 9520006 [TBL] [Abstract][Full Text] [Related]
5. Impact of APOE genotype on neuropathologic and neurochemical markers of Alzheimer disease. Tiraboschi P; Hansen LA; Masliah E; Alford M; Thal LJ; Corey-Bloom J Neurology; 2004 Jun; 62(11):1977-83. PubMed ID: 15184600 [TBL] [Abstract][Full Text] [Related]
6. Association Between Apolipoprotein E ε2 vs ε4, Age, and β-Amyloid in Adults Without Cognitive Impairment. Insel PS; Hansson O; Mattsson-Carlgren N JAMA Neurol; 2021 Feb; 78(2):229-235. PubMed ID: 33044487 [TBL] [Abstract][Full Text] [Related]
7. Association of β-Amyloid and Apolipoprotein E ε4 With Memory Decline in Preclinical Alzheimer Disease. Lim YY; Kalinowski P; Pietrzak RH; Laws SM; Burnham SC; Ames D; Villemagne VL; Fowler CJ; Rainey-Smith SR; Martins RN; Rowe CC; Masters CL; Maruff PT JAMA Neurol; 2018 Apr; 75(4):488-494. PubMed ID: 29356823 [TBL] [Abstract][Full Text] [Related]
9. Association of Brain Amyloid-β With Slow Gait in Elderly Individuals Without Dementia: Influence of Cognition and Apolipoprotein E ε4 Genotype. Nadkarni NK; Perera S; Snitz BE; Mathis CA; Price J; Williamson JD; DeKosky ST; Klunk WE; Lopez OL JAMA Neurol; 2017 Jan; 74(1):82-90. PubMed ID: 27842173 [TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease. Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O; JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367 [TBL] [Abstract][Full Text] [Related]
11. Sex-Specific Association of Apolipoprotein E With Cerebrospinal Fluid Levels of Tau. Hohman TJ; Dumitrescu L; Barnes LL; Thambisetty M; Beecham G; Kunkle B; Gifford KA; Bush WS; Chibnik LB; Mukherjee S; De Jager PL; Kukull W; Crane PK; Resnick SM; Keene CD; Montine TJ; Schellenberg GD; Haines JL; Zetterberg H; Blennow K; Larson EB; Johnson SC; Albert M; Bennett DA; Schneider JA; Jefferson AL; JAMA Neurol; 2018 Aug; 75(8):989-998. PubMed ID: 29801024 [TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein E allelotype is associated with neuropathological findings in Alzheimer's disease. Kumar NT; Liestøl K; Løberg EM; Reims HM; Mæhlen J Virchows Arch; 2015 Aug; 467(2):225-35. PubMed ID: 25898889 [TBL] [Abstract][Full Text] [Related]
13. Apolipoprotein E ε4 allele interacts with sex and cognitive status to influence all-cause and cause-specific mortality in U.S. older adults. Beydoun MA; Beydoun HA; Kaufman JS; An Y; Resnick SM; O'Brien R; Ferrucci L; Zonderman AB J Am Geriatr Soc; 2013 Apr; 61(4):525-34. PubMed ID: 23581910 [TBL] [Abstract][Full Text] [Related]
14. Statin Initiation and Risk of Incident Alzheimer Disease and Cognitive Decline in Genetically Susceptible Older Adults. Rajan KB; Mcaninch EA; Wilson RS; Dhana A; Evans-Lacko S; Evans DA Neurology; 2024 Apr; 102(7):e209168. PubMed ID: 38447103 [TBL] [Abstract][Full Text] [Related]
15. Age and the association between apolipoprotein E genotype and Alzheimer disease: A cerebrospinal fluid biomarker-based case-control study. Saddiki H; Fayosse A; Cognat E; Sabia S; Engelborghs S; Wallon D; Alexopoulos P; Blennow K; Zetterberg H; Parnetti L; Zerr I; Hermann P; Gabelle A; Boada M; Orellana A; de Rojas I; Lilamand M; Bjerke M; Van Broeckhoven C; Farotti L; Salvadori N; Diehl-Schmid J; Grimmer T; Hourregue C; Dugravot A; Nicolas G; Laplanche JL; Lehmann S; Bouaziz-Amar E; ; Hugon J; Tzourio C; Singh-Manoux A; Paquet C; Dumurgier J PLoS Med; 2020 Aug; 17(8):e1003289. PubMed ID: 32817639 [TBL] [Abstract][Full Text] [Related]
16. APOE ε4, Alzheimer's disease neuropathology and sleep disturbance, in individuals with and without dementia. Blackman J; Love S; Sinclair L; Cain R; Coulthard E Alzheimers Res Ther; 2022 Mar; 14(1):47. PubMed ID: 35354468 [TBL] [Abstract][Full Text] [Related]
17. The effect of APOE-epsilon4 on dementia is mediated by Alzheimer neuropathology. Mortimer JA; Snowdon DA; Markesbery WR Alzheimer Dis Assoc Disord; 2009; 23(2):152-7. PubMed ID: 19484916 [TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein E epsilon4 allele, AD pathology, and the clinical expression of Alzheimer's disease. Bennett DA; Wilson RS; Schneider JA; Evans DA; Aggarwal NT; Arnold SE; Cochran EJ; Berry-Kravis E; Bienias JL Neurology; 2003 Jan; 60(2):246-52. PubMed ID: 12552039 [TBL] [Abstract][Full Text] [Related]
19. Enhanced risk for Alzheimer disease in persons with type 2 diabetes and APOE epsilon4: the Cardiovascular Health Study Cognition Study. Irie F; Fitzpatrick AL; Lopez OL; Kuller LH; Peila R; Newman AB; Launer LJ Arch Neurol; 2008 Jan; 65(1):89-93. PubMed ID: 18195144 [TBL] [Abstract][Full Text] [Related]
20. Increased Alzheimer's disease neuropathology is associated with type 2 diabetes and ApoE ε.4 carrier status. Malek-Ahmadi M; Beach T; Obradov A; Sue L; Belden C; Davis K; Walker DG; Lue L; Adem A; Sabbagh MN Curr Alzheimer Res; 2013 Jul; 10(6):654-9. PubMed ID: 23627755 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]